Yifeng Pharmacy Chain Co., Ltd., a listed company, is committed to providing value-added goods and services for the healthy life of the people, and is a well-known large-scale affordable drug supermarket chain enterprise in China
Yifeng Pharmacy Chain Co., Ltd. is a leading large-scale pharmaceutical retail chain enterprise in China. The company always holds high the banner of "parity and professionalism", adheres to the enterprise spirit of "integrity, dedication, pragmatism and innovation", and provides value-added goods and services for the healthy life of the people. At present, the company has opened more than 680 directly operated pharmaceutical chain stores in six provinces and cities including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang and Jiangxi. According to the statistics of industry institutions, the company ranks among the top three in pharmaceutical retail in Central China and East China; It ranks sixth in the comprehensive strength of chain pharmacies in the country. The company not only pays attention to rapid expansion, but also pays more attention to refined management and operation. Through the implementation of seven core systems, including the customer satisfaction evaluation system, the company has refined management of customer service, store operation, commodity procurement, business analysis, quality control, store location, performance evaluation and other links, so as to continuously improve the company's operating efficiency and competitiveness.
The company takes customer satisfaction as the standard to measure all work, and combines customer satisfaction with employee performance appraisal to ensure the consistency of customer value and the company's sustainable profitability.
In the past two years, the company has successfully implemented the world's leading ERP information system and WMS logistics management system, and invested in the construction of a large-scale group logistics center, which will further enhance the unified management level of people, finance and materials, and fully realize the transformation from the traditional logistics model to the supply chain management model, which will effectively improve logistics efficiency and reduce logistics costs.
The company's development strategy is: "consolidate Central and South China, expand the national market", build a leading brand in the pharmaceutical industry trusted by the people and respected by the society, and provide value-added goods and services for human health. In the next three years, the company will implement the "regional focus" development strategy in Central and East China, further enhance the company's market share and brand influence in Central and East China, and actively try diversified new forms of big health to build the company's sustainable competitiveness.
